Information:
Fel:
ID
20568
Beskrivning
PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327); ODM derived from: https://clinicaltrials.gov/show/NCT00536263
Länk
https://clinicaltrials.gov/show/NCT00536263
Nyckelord
Versioner (1)
- 2017-03-03 2017-03-03 -
Uppladdad den
3 mars 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatitis B, Chronic NCT00536263
Eligibility Hepatitis B, Chronic NCT00536263
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis B, Chronic NCT00536263
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
adults with chronic hepatitis b
Item
adults with chronic hepatitis b:
boolean
C0001675 (UMLS CUI [1])
C0524909 (UMLS CUI [2])
C0524909 (UMLS CUI [2])
hbsag
Item
serum hepatitis b surface antigen positive for at least 6 months
boolean
C0019168 (UMLS CUI [1])
hbeag
Item
serum hepatitis b e antigen positive
boolean
C0019167 (UMLS CUI [1])
anti hbs, anti hbe
Item
serum negative for hepatitis b surface and e antibodies
boolean
C0201478 (UMLS CUI [1])
C0948252 (UMLS CUI [2])
C0948252 (UMLS CUI [2])
hepatitis b virus dna
Item
plasma hepatitis b virus deoxyribonucleic acid (dna) level greater than 20,000 iu/ml
boolean
C3641250 (UMLS CUI [1])
alt
Item
alanine aminotransferase (alt) 2- to 10-times the upper limit of normal
boolean
C0201836 (UMLS CUI [1])
compensated liver disease
Item
compensated liver disease with certain minimum hematological and serum biochemical criteria
boolean
C3839044 (UMLS CUI [1])
significant liver disease, etiology other than hepatitis b virus
Item
significant hepatic disease from an etiology other than hepatitis b virus
boolean
C0023895 (UMLS CUI [1])
C1298908 (UMLS CUI [2,1])
C0019163 (UMLS CUI [2,2])
C1298908 (UMLS CUI [2,1])
C0019163 (UMLS CUI [2,2])
antiviral treatment hepatitis
Item
antiviral treatment for hepatitis within previous 6 months
boolean
C2363964 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
C0019163 (UMLS CUI [1,2])
history of mental disorder
Item
history of severe psychiatric disease, especially depression
boolean
C0455498 (UMLS CUI [1])
C0262926 (UMLS CUI [2,1])
C0011581 (UMLS CUI [2,2])
C0262926 (UMLS CUI [2,1])
C0011581 (UMLS CUI [2,2])
unstable or significant cardiovascular disease
Item
unstable or significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,3])
C0443343 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,3])
prolonged exposure to known hepatotoxins such as alcohol or drugs
Item
prolonged exposure to known hepatotoxins such as alcohol or drugs
boolean
C0596691 (UMLS CUI [1])
C0038586 (UMLS CUI [2])
C0038586 (UMLS CUI [2])
comorbidity, limited protocol compliance
Item
any condition that could interfere with the subject participating in and completing the study
boolean
C0009488 (UMLS CUI [1])
C0439801 (UMLS CUI [2,1])
C0525058 (UMLS CUI [2,2])
C0439801 (UMLS CUI [2,1])
C0525058 (UMLS CUI [2,2])